Magnetic Resonance Fingerprinting for Preoperative Evaluation of Lymphovascular Space Invasion in Early Stage Cervical Cancer

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05808933

Acronym

MARF-ESC

Enrollment

150

Registered

2023-04-12

Start date

2022-06-20

Completion date

2027-12-31

Last updated

2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancer

Brief summary

The aim of this observational prospective study is to investigate the role of Magnetic Resonance Fingerprinting in preoperative assessment of early cervical cancer

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients with biopsy-proven cervical cancer FIGO stage IA-IIA undergoing surgery; * Women aged \>18 years old; * Signed Informed Consent.

Exclusion criteria

* Concurrent malignancies at other sites; * Previous history of neoplasm; * Refusal to sign written informed consent

Design outcomes

Primary

Measure	Time frame
Association between T1-, T2- and ADC-maps and LVSI status	3 months

Secondary

Measure	Time frame
Correlation between T1-, T2- and ADC-maps and DFS and OS	3 years
Correlation between Radiomics-based analysis and LVSI status and DFS and OS	3 years

Countries

Italy

Contacts

Primary ContactBenedetta B Gui, MD

benedetta.gui@policlinicogemelli.it0630155464

Backup ContactLuca L Russo, MD

luca.russo@guest.policlinicogemelli.it0630156054

Outcome results